Related references
Note: Only part of the references are listed.A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products
David J. Nutt et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
Crosstalk of the Wnt/β-Catenin Signaling Pathway in the Induction of Apoptosis on Cancer Cells
Cristina Trejo-Solis et al.
PHARMACEUTICALS (2021)
Cannabis-Derived Compounds Cannabichromene and Δ9-Tetrahydrocannabinol Interact and Exhibit Cytotoxic Activity against Urothelial Cell Carcinoma Correlated with Inhibition of Cell Migration and Cytoskeleton Organization
Omer Anis et al.
MOLECULES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
WNT inhibition creates a BRCA-like state in Wnt-addicted cancer
Amanpreet Kaur et al.
EMBO MOLECULAR MEDICINE (2021)
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
Usha Menon et al.
LANCET (2021)
Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro
Hadar Peeri et al.
CANCERS (2021)
Study on the clinical significance of TRPV2 and MMP2 expressions in ovarian cancer
Xiaopang Ren et al.
BIOCELL (2021)
Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy
Vignesh Narasimhan et al.
CLINICAL CANCER RESEARCH (2020)
CBD Reverts the Mesenchymal Invasive Phenotype of Breast Cancer Cells Induced by the Inflammatory Cytokine IL-1β
Lazaro Garcia-Morales et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Synergistic cytotoxic activity of cannabinoids from cannabis sativa against cutaneous T-cell lymphoma (CTCL) in-vitro and ex-vivo
Moran Mazuz et al.
Oncotarget (2020)
PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment
Ana Fraguas-Sanchez et al.
PHARMACEUTICS (2020)
Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis
Andrea M. Tomko et al.
CANCERS (2020)
Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles
A. Fraguas-Sanchez et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Phytocannabinoids: Origins and Biosynthesis
Thies Gulck et al.
TRENDS IN PLANT SCIENCE (2020)
Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain
Yedukondalu Nalli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling
Wei Hu et al.
SCIENTIFIC REPORTS (2019)
A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24
Mansoor Raza Mirza et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey
Jamie Corroon et al.
BMC FAMILY PRACTICE (2019)
Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis
Vu Hong Loan Nguyen et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights
Sonal Patel et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dramatic response to Laetrile and cannabidiol (CBD) oil in a patient with metastatic low grade serous ovarian carcinoma
Allison M. Barrie et al.
GYNECOLOGIC ONCOLOGY REPORTS (2019)
Advances in ovarian cancer therapy
Alexander J. Cortez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway
Chunyan Wei et al.
GENE (2017)
Potential role and prognostic importance of dishevelled-2 in epithelial ovarian cancer
Rong Liu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2017)
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Chantal Pauli et al.
CANCER DISCOVERY (2017)
Niraparib in ovarian cancer: results to date and clinical potential
Davide Caruso et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2017)
Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes
Oier Aizpurua-Olaizola et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Phytocannabinoids: a unified critical inventory
Lumir Ondrej Hanus et al.
NATURAL PRODUCT REPORTS (2016)
Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling
S. Bernaudo et al.
ONCOGENE (2016)
Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/β-catenin pathway
Bo Li et al.
ONCOTARGET (2016)
In vivo tumor growth of high-grade serous ovarian cancer cell lines
Anirban K. Mitra et al.
GYNECOLOGIC ONCOLOGY (2015)
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
The Wnt/β-catenin pathway in ovarian cancer: A review
Rebecca C. Arend et al.
GYNECOLOGIC ONCOLOGY (2013)
Towards the use of cannabinoids as antitumour agents
Guillermo Velasco et al.
NATURE REVIEWS CANCER (2012)
The Levels of the Endocannabinoid Receptor CB2 and Its Ligand 2-Arachidonoylglycerol Are Elevated in Endometrial Carcinoma
Maurizio Guida et al.
ENDOCRINOLOGY (2010)
Share Paper
